Focal and segmental glomerulosclerosis: Analogies to atherosclerosis
Open accessAbstract
In summary, both the developing atherosclerotic and FSGS lesions seem to share certain postulated pathophysiologic mechanisms, including endothelial cell injury, macrophage infiltration, hyperlipoproteinemia, and hypertension. As depicted in Figure 1, any initial glomerular injury results in flux of macromolecular substances into the glomerular mesangium. As an adjunct to increased glomerular barrier dysfunction, hyperlipoproteinemia is believed to secondarily develop from the dramatic losses of albumin, stimulating increased hepatic lipoprotein synthesis and the loss of lipoprotein lipase-activating substance into the urine which would effectively produce a reduction in circulating chylomicra and triglyceride catabolism. Certain elevated circulating lipoproteins could, theoretically, pass through the damaged glomerular filter into the mesangium, thereby enhancing the flux of macromolecules. Also associated with certain experimental glomerular disorders is the development of glomerular hypertension, as manifested by an elevated glomerular capillary hydrostatic pressure (PGC), which can further augment macromolecular flux into the mesangium. Overloading of the glomerular mesangium by the above mechanisms is believed to be an injurious stimulus for MC to both proliferate and produce excess mesangial matrix substance. Both of these events are thought to be pathologic harbingers of glomerulosclerosis. Glomerular hypertension is also capable of damaging endothelial cells within th…
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Dyslipidemia and apoE abnormalities influence the foamy change of macrophages and mesangial cells.
“With respect to the onset of FSGS, dyslipidemia [7] and apoE abnormalities [8] also influence the foamy change of macrophages and mesangial cells”
From Focal segmental glomerulosclerosis with heterozygous apolipoprotein E5 (Glu3Lys) (2018) · cites this paper as [7]
Cited by
Sorted by citations
Chen, X.-L., Dodd, G., Thomas, S., Zhang, X., Wasserman, M. A., Rovin, B. H., & Kunsch, C. (2006) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00651.2005 · Cited by 418 · see citing works
Estrogen-induced cardiorenal protection: potential cellular, biochemical and molecular mechanisms.
Dubey, R. K., & Jackson, E. K. (2001) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.2001.280.3.f365 · Cited by 263 · see citing works
Apolipoprotein E–related glomerular disorders
Saito, T., Matsunaga, A., Fukunaga, M., Nagahama, K., Hara, S., & Muso, E. (2020) · Kidney International · doi:10.1016/j.kint.2019.10.031 · Cited by 77 · see citing works
Focal segmental glomerulosclerosis with heterozygous apolipoprotein E5 (Glu3Lys)
Sasaki, M., Yasuno, T., Ito, K., Matsunaga, A., Hisano, S., Abe, Y., Miyake, K., Masutani, K., Nakashima, H., & Saito, T. (2018) · CEN Case Reports · doi:10.1007/s13730-018-0331-4 · Cited by 9 · see citing works
- Authors
- Diamond, J. R., & Karnovsky, M. J.
- Affiliations
- Harvard University (US)
- Venue
- Kidney International
- Publisher
- Elsevier BV
- Published
- 1988-05
- Volume
- 33
- Issue
- 5
- Pages
- 917-924
- ISSN
- 0085-2538 (ISSN-L)
- OpenAlex
- W2030089656
- Cited by
- 330
- References
- 0
- Citations by year
- 2026: 1 · 2024: 3 · 2023: 6 · 2021: 2 · 2020: 3 · 2019: 6 · 2018: 3 · 2017: 3 · 2016: 4 · 2015: 7 · 2014: 2 · 2013: 7 · 2012: 1
- FWCI
- 4.11
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Kidney International (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (2r01am013132-16a1)
- Topics
- Health Sciences › Medicine › Nephrology › Renal Diseases and Glomerulopathies
- Health Sciences › Medicine › Nephrology › Chronic Kidney Disease and Diabetes
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Renal and Vascular Pathologies
- Keywords
- focal segmental glomerulosclerosis, atherosclerosis, glomerular hypertension, mesangial cell proliferation, mesangial matrix, endothelial injury, macrophage infiltration, hyperlipoproteinemia, albuminuria, lipoprotein lipase, glomerular thrombosis, pathophysiology
- MeSH terms
- Animals, Arteriosclerosis, Cell Division, Endothelium, Vascular, Glomerulonephritis, Glomerulosclerosis, Focal Segmental, Humans, Hypertension, Renovascular, Models, Biological
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review